GRAND RAPIDS, Mich.,
May 30, 2013 /PRNewswire/ --
Oncologix Tech Inc. (OTCBB: OCLG), a diversified medical device and
healthcare services company operating businesses in medical device
cancer detection, prevention and healthcare services, has
opened negotiations to acquire two healthcare service providers.
"We have signed non-binding letters of intent with two leading
providers of healthcare services to the elderly and expect to
announce the details of that transaction, as well as one other, in
the next 45 days," said CEO Wayne
Erwin today.
"This is a critical first step in expanding Oncologix's two-fold
strategic mission," he said. "With the acquistion of Dotolo, a
leading medical device manufacturer, now complete, we will
establish our healthcare services divisions, hopefully, with one of
these acquisitions. This will enable us to expand our efforts in
both divisions as we build out OCLG operations."
Mr. Erwin also noted that negotiations to reduce OCLG's debt are
now underway and that the Company seeks s to significantly cut its
debt and improve its balance sheet following the completion of
negotiations with a few creditors "We are determined to position
OCLG for growth and profitability, built on the strength of our
existing operations and new acquisitions."
This press release may contain forward-looking statements, made
in reliance upon Section 21D of the Exchange Act of 1934, which
involve known and unknown risks, uncertainties or other factors
that could cause actual results to differ materially from the
results, performance, or expectations implied by these
forward-looking statements. The Company's expectations, among other
things, are dependent upon economic conditions, continued demand
for its products, the availability of raw materials, retention of
its key management and operating personnel, its ability to operate
its subsidiary companies effectively, need for and availability of
more capital as well as other uncontrollable or unknown factors
which are more fully disclosed in the Company's filings with the
Securities and Exchange Commission.
About Oncologix Tech, Inc.:
Oncologix operates medical device and healthcare services
companies. For its clients, Oncologix provides FDA approved medical
devices and state approved healthcare services. For its
shareholders, Oncologix operates profitable operations that build,
maintain and nourish shareholder value. The Company's corporate
mission is to be the best small cap medical device and healthcare
services company in North
America.
Contact
Information
|
Contact:
|
Wayne Erwin,
CEO
|
|
wayne.erwin@oncologix.biz
|
|
(318)769-1958
|
SOURCE Oncologix Tech Inc.